There is a growing evidence indicating that reducing Treg cells leads to a rise in the amount of CD4+ and/or CD8+ effector T cells (Teffs) within tumors, enhancing the body's ability to fight against tumors and resulting in tumor rejection [34]. The gene discussed is CD8A; the disease is neoplasm.